Inspire Medical Systems Inc. (INSP) exhibits 85.4% gross margins and 6.0% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 23.3x enterprise multiple and 4.8% implied options volatility.
Sustained 85.4% gross profitability converts into 5.6% operating margin and 6.0% ROIC, outpacing sector cost of capital.
ROIC: 6.0% // GM: 85.4%YoY revenue trajectory of +13.6% paired with 3.81% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +13.6% // FCF YLD: 3.81%Altman Z-Score of 11.40 and Piotroski F-Score of 7/9 indicate low near-term refinancing stress.
ALTMAN Z: 11.40 // F-SCORE: 7/9Trading at 14.2x trailing P/E (11.9x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 14.2x // EV/EBITDA: 23.3xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $68.10 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend 15.9% net margins.
NET MARGIN: 15.9% // D/E: 0.45x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for INSP & activate live FRED threshold breach alerts.